Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [522]
News [1466]
Articles [67]
Editorials [2]
Conferences [72]
elearning [5]
Highlights of the EurocanPlatform Project
Highlights of the EurocanPlatform Project ( )
2 Dec 2015
Cancer Core Europe: one year on (full version)
Prof Alexander Eggermont - Gustave Roussy, Villejuf, France
Cancer Core Europe: one year on (full version) ( Prof Alexander Eggermont - Gustave Roussy, Villejuf, France )
2 Dec 2015
Cancer Prevention Europe
Dr Chris Wild - International Agency for Research on Cancer (IARC), Lyon, France
Cancer Prevention Europe ( Dr Chris Wild - International Agency for Research on Cancer (IARC), Lyon, France )
2 Dec 2015
What is the relationship between PD-L1 expression and antitumour activity?
Dr Paolo Ascierto - National Tumor Institute, Naples, Italy
What is the relationship between PD-L1 expression and antitumour activity? ( Dr Paolo Ascierto - National Tumor Institute, Naples, Italy )
19 Nov 2015
Prognostic value of BRAFV600 mutations in stage 3 cutaneous melanoma patients
Prof Philippe Saiag - University of Versailles, Versailles, France
Prognostic value of BRAFV600 mutations in stage 3 cutaneous melanoma patients ( Prof Philippe Saiag - University of Versailles, Versailles, France )
5 Nov 2015
What are the prognostic values of 25-hydroxyvitamin D3 levels at diagnosis and...
Prof Philippe Saiag - University of Versailles, Versailles, France
What are the prognostic values of 25-hydroxyvitamin D3 levels at diagnosis and follow-up? ( Prof Philippe Saiag - University of Versailles, Versailles, France )
5 Nov 2015
Anti-PD1 or tyrosine kinase inhibitors?
Dr Mark Middleton - University of Oxford, Oxford, UK
Anti-PD1 or tyrosine kinase inhibitors? ( Dr Mark Middleton - University of Oxford, Oxford, UK )
5 Nov 2015
New drugs and new trials in melanoma
Prof Jean-Jacques Grob - Marseille University, Marseille, France
New drugs and new trials in melanoma ( Prof Jean-Jacques Grob - Marseille University, Marseille, France )
5 Nov 2015
Highlights of EADO 2015
Prof Jean-Jacques Grob - Marseille University, Marseille, France
Highlights of EADO 2015 ( Prof Jean-Jacques Grob - Marseille University, Marseille, France )
5 Nov 2015
Disruptive technologies in cancer
Prof Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia
Disruptive technologies in cancer ( Prof Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia )
5 Nov 2015
Latest from the CoBRIM study
Prof Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia
Latest from the CoBRIM study ( Prof Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia )
5 Nov 2015
Anti-PD-1 or anti-CTLA-4 in first line therapy?
Prof Claus Garbe - University of Tübingen, Tübingen, Germany
Anti-PD-1 or anti-CTLA-4 in first line therapy? ( Prof Claus Garbe - University of Tübingen, Tübingen, Germany )
5 Nov 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation